# FDA Inspection 1121166 - SeQuent Research Limited - February 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/sequent-research-limited/ec16f0f2-202a-4141-99de-93b35855a084
Source feed: FDA_Inspections

> FDA Inspection 1121166 for SeQuent Research Limited on February 14, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121166
- Company Name: SeQuent Research Limited
- Inspection Date: 2020-02-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1286970 - 2025-09-03](https://www.keypedia.com/records/fda_inspections/sequent-research-limited/7cdcd07f-31fc-4dbc-a27f-178236f2e560)
- [FDA Inspection 1286970 - 2025-09-03](https://www.keypedia.com/records/fda_inspections/sequent-research-limited/72b0fc90-cf18-47bf-9693-37d3df63dd44)

Company: https://www.keypedia.com/companies/sequent-research-limited/ae5e367b-3cbe-428f-b4c5-02ab7b85c6b5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c